Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. 2005N-0216]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the 
                        ( print page 61456)
                        Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
 DATES: Fax written comments on the collection of information by November 23, 2005.
 ADDRESSES: OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted.  To ensure that comments on the information collection are received, OMB recommends that comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn:  Fumie Yokota, Desk Officer for FDA, FAX:  202-395-6974.
 FOR FURTHER INFORMATION CONTACT: Peggy Robbins, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.


SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Medical Devices:  Humanitarian Use Devices—21 CFR Part 814 (OMB Control Number 0910-0332)—Extension This collection implements the humanitarian use device (HUD) Provision under section 520(m) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360j(m)) and 21 CFR part 814, subpart H. Under section 520(m) of the act, FDA is authorized to exempt an HUD from the effectiveness requirements of sections 514 and 515 of the act (21 U.S.C. 360d and 360e) provided that the device do the following:  (1) Is used to treat or diagnosis a disease or condition that affects fewer than 4,000 individuals in the United States; (2) would not be available to a person with such a disease or condition unless the exemption is granted, and there is no comparable device, other than another HUD approved under this exemption, available to treat or diagnose the disease or condition; and (3) the device will not expose patients to an unreasonable or significant risk of illness or injury, and the probable benefit to health from using the device outweighs the risk of injury or illness from its use, taking into account the probable risks and benefits of currently available devices or alternative forms of treatment. The information collection will allow FDA to determine whether to do the following:  (1) Grant HUD designation of a medical device, (2) exempt a HUD from the effectiveness requirements in sections 514 and 515 of the act provided that the device meets requirements set forth in section 520(m) of the act, and (3) grants marketing approval(s) for the HUD. Failure to collect this information would prevent FDA from making those determinations. Also, this information enables FDA to determine whether the holder of a HUD is in compliance with the HUD requirements. *Description of Respondents*:  Businesses or others for-profit. In the 
                    **Federal Register**
                     of June 16, 2005 (70 FR 35098), FDA published a 60-day notice requesting public comment on the information collection provisions.  No comments were received. FDA estimates the burden of this collection of information as follows: **Table 1—Estimated Annual Reporting Burden1**
21 CFR Section
No. of Respondents
Annual Frequency per Respondent
Total Annual Responses
Hours per Response
Total Hours814.102
20
1
20
40
800814.104
8
1
8
320
2,560814.106
8
2
16
50
800814.108
20
1
20
80
1,600814.116(e)(3)
1
1
1
1
1814.124(a)
5
1
5
1
5814.124(b)
1
1
1
2
2814.126(b)(1)
35
1
35
120
4,200Total




9,9681
                        There are no capital costs or operating and maintenance costs associated with this collection of information.
 **Table 2.—Estimated Annual Recordkeeping Burden1**
21 CFR Section
No. of Recordkeepers
Annual Frequency per Recordkeeping
Total Annual Records
Hours per Recordkeeper
Total Hours814.126(b)(2)
35
1
35
2
701
                        There are no capital costs or operating and maintenance costs associated with this collection of information.
 Dated: October 17, 2005. Jeffrey Shuren, Assistant Commissioner for Policy.


[FR Doc. 05-21158 Filed 10-21-05; 8:45 am] BILLING CODE 4160-01-S